Data from Balance between Polyoma Enhancing Activator 3 and Activator Protein 1 Regulates <i>Helicobacter pylori</i>–Stimulated Matrix Metalloproteinase 1 Expression

Jeng Yih Wu,Hong Lu,Yubo Sun,David Y. Graham,Herman S. Cheung,Yoshio Yamaoka
DOI: https://doi.org/10.1158/0008-5472.c.6494573
2023-01-01
Abstract:<div>Abstract<p><i>Helicobacter pylori</i> infection and elevated expression of tissue matrix metalloproteinase 1 (MMP-1) are both associated with gastric cancer. We investigated the regulation of MMP-1 expression during <i>H. pylori</i> infection. Real-time reverse transcription-PCR was used to examine mucosal MMP-1 mRNA levels in 55 patients with gastric cancers and 61 control patients. Increased MMP-1 mRNA levels in the gastric mucosa and epithelial cells were observed in <i>H. pylori</i> infections in which both the <i>cag</i> pathogenicity island (PAI) and outer inflammatory protein A (OipA) were expressed. The combined induction of <i>c-fos, c-jun</i>, and polyoma enhancing activator-3 (<i>pea-3</i>) by <i>H. pylori</i> caused maximal increase in MMP-1 expression. Activation of the MMP-1 promoter by <i>H. pylori</i> involved occupation of the activator protein 1 (AP-1) sites at −72 and −181 and, surprisingly, vacancy of the −88 PEA-3 site. Electrophoretic mobility shift, supershift, and chromatin immunoprecipitation assays showed increased binding of c-Fos and c-Jun to the −72 and −181 AP-1 sites during <i>H. pylori</i> infection. Importantly, during wild-type <i>H. pylori</i> infection, we detected increased PEA-3 binding to the −72AP-1 site and decreased PEA-3 binding to the −88 PEA-3 site. However, during infection with the <i>cag</i> PAI and <i>oipA</i> mutants, PEA-3 binding to the −88 site was detected. MMP-1 and <i>pea-3</i> activities are increased in gastric cancers. Maximal activation of MMP-1 transcription requires the <i>cag</i> PAI and OipA, which regulate AP-1 and PEA-3 binding. Thus, <i>cag</i> PAI and OipA provide a possible link between bacterial virulence factors and important host factors related to disease pathogenesis. (Cancer Res 2006; 66(10): 5111-20)</p></div>
What problem does this paper attempt to address?